Publications Archives - Page 2 of 2 - Syngene International Ltd

Publications

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Characterization of acquired resistance mutations to menin inhibitors

Publication: American Association for Cancer Research

1st Apr, 2023

Read

LP-07 In silico analysis using Derek and Sarah along with ICH M7 expert review accurately predicts Mutagenicity and Carcinogenicity of Nitrosamines

Publication: Toxicology Letters

30th Aug, 2022

Read

Challenges in setting permitted daily exposure limits for pharmaceuticals: A review

Publication: National Library of Medicine; International Journal of Risk & Safety in Medicine

20th Feb, 2022

Read

Approaches for setting occupational exposure limits in the pharmaceutical industry

Publication: Journal of Applied Toxicology Wiley

22nd Jun, 2021

Read

TNB-738, a biparatopic antibody, boosts intracellular NAD+ by inhibiting CD38 ecto-enzyme activity

Publication: mAbs

18th Jul, 2022

Read

Structure-Based Optimization and Discovery of M3258, a Specific Inhibitor of the Immunoproteasome Subunit LMP7 (β5i)

Publication: Journal of Medicinal Chemistry

5th Jul, 2021

Read

Potent antimalarials with development potential identified by structure-guided computational optimization of a pyrrole-based dihydroorotate dehydrogenase inhibitor series

Publication: Journal of Medicinal Chemistry

19th Apr, 2021

Read

Solvent-Dependent Photophysics and Reactivity of Monomeric and Dimeric 4-Amino-1,8-Naphthalimides

Publication: The Journal of Physical Chemistry A

15th Mar, 2021

Read

Synthetic platform for mono-functionalised tridentate macrocycles as key precursors of mechanically-linked macromolecular systems

Publication: Organic Chemistry Frontiers

7th Mar, 2021

Read

US FDA approved drugs from 2015-June 2020-A perspective